Logo

One year in review 2017: novelties in the treatment of rheumatoid arthritis

1, 2, 3, 4, 5

  1. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. francescoferrodoc@gmail.com
  2. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  3. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  4. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  5. Department of Rheumatology, IRCCS S. Matteo, University of Pavia, Italy.

CER10750 Submission on line
2017 Vol.35, N°5 - PI 0721, PF 0734
Review

Free to view (click on article PDF icon to read the article)

Rheumatology Article

 

Abstract

Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to control pain and inflammation, reduce joint damage and disability, and maintain or improve physical function and quality of life. The present review is aimed at providing a critical analysis of the recent literature on the novelties in the treatment of RA, with a particular focus on the most relevant studies published over the last year.

PMID: 28956527 [PubMed]

Received: 14/08/2017 - Accepted : 28/08/2017 - In Press: 13/09/2017 - Published: 13/09/2017